Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Breast Cancer That Involves No More Than 3 Lymph Nodes
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: anthracycline-based|DRUG: docetaxel and capecitabine|DRUG: tamoxifen|DRUG: Letrozole
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Collaborators: Agendia|Breast International Group|Roche Pharma AG|Novartis|Sanofi